Chase Labs Nj Company Profile
✉ Email this page to a colleague
What is the competitive landscape for CHASE LABS NJ
CHASE LABS NJ has two approved drugs.
Drugs and US Patents for Chase Labs Nj
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chase Labs Nj | NIFEDIPINE | nifedipine | CAPSULE;ORAL | 073421-001 | Jun 19, 1991 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| Chase Labs Nj | NIFEDIPINE | nifedipine | CAPSULE;ORAL | 072409-001 | Jul 4, 1990 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.

